5-Fluorocytosine-mediated apoptosis and DNA damage in glioma cells engineered to express cytosine deaminase and their enhancement with interferon

Journal of Neuro-Oncology

Volumn 36, Issue 3, 1998, Pages 219-229

  Wang, Zhao Hui ^a   Samuels, Stanley ^a   Gama Sosa, Miguel A ^a   Kolodny, Edwin H ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

5 fluorocytosine; Apoptosis; Bacterial cytosine deaminase; DNA damage; Glioma cell; Interferon

Indexed keywords

CYTOSINE DEAMINASE; FLUCYTOSINE; INTERFERON; THYMIDYLATE SYNTHASE;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; DNA DAMAGE; DNA SYNTHESIS INHIBITION; DRUG MECHANISM; GLIOMA CELL; NONHUMAN; RAT;

3T3 CELLS; ANIMALS; APOPTOSIS; CYTOSINE DEAMINASE; DNA; DNA DAMAGE; DRUG SYNERGISM; FLUCYTOSINE; GLIOMA; INTERFERONS; MICE; NUCLEOSIDE DEAMINASES; RATS; THYMIDYLATE SYNTHASE; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0031932332     PISSN: 0167594X     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1005883128175     Document Type: Article

References (28)

1. Takamiya Y, Short MP, Moolten FL, Fleet C, Mineta T, Breakefield XO, Martuza RL: An experimental model of retrovirus gene therapy for malignant brain tumors. J Neurosurg 79: 104-110, 1993
2. Ram Z, Culver KW, Walbridge S, Blaese RM, Oldfield EH: In situ retroviral-mediated gene transfer for the treatment of brain tumors in rats. Cancer Res 53: 83-88, 1993
3. Boviatsis EJ, Chase M, Wei MX, Tamiya T, Hurford RK Jr, Kowall NW, Tepper RI, Breakefield XO, Chiocca EA: Gene transfer into experimental brain tumors mediated by adenovirus, herpes simplex virus, and retrovirus vectors. Hum Gene Therapy 5: 183-191, 1994
4. Kramm CM, Sena-Esteves M, Barnett FH, Rainov NG, Schuback DE, Yu JS, Pechan PA, Paulus W, Chiocca EA, Breakefield XO: Gene therapy for brain tumors. Br Pathol 5: 345-381, 1995
5. Mullen CA, Kilstrup M, Blaese RM: Transfer of the bacterial gene for cytosine deaminase to mammalian cells confers lethal sensitivity to 5′-fluorocytosine: a negative selection system. Proc Natl Acad Sci USA 89: 33-37, 1992
6. Consalvo M, Mullen CA, Modesti A, Musiani P, Allione A, Cavallo F, Giovarelli M, Forni G: 5-fluorocytosine-induced eradiction of murine adenocarcinomas engineered to express the cytosine deaminase suicide gene requires host immune competence and leaves an efficient memory. J Immunol 154: 5302-5312, 1995
7. Huber BE, Austin EA, Good SS, Knick VC, Tibbels S, Richards CA: In vivo antitumor activity of 5-fluorocytosine on human colorectal carcinoma cells genetically modified to express cytosine deaminase. Cancer Res 53: 4619-4626, 1993
8. Harris JD, Gutierrez AA, Hurst HC, Sikora K, Lemoine NR: Gene therapy for cancer using tumor-specific prodrug activation. Gene Therapy 1: 170-175, 1994
9. Huber BE, Austin EA, Richards CA, Davis ST, Good SS: Metabolism of 5-fluorocytosine to 5-fluorouracil in human colorectal tumor cells transduced with the cytosine deaminase gene: significant antitumor effects when only a small percentage of tumor cells express cytosine deaminase. Proc Natl Acad Sci USA 91: 8302-8306, 1994
10. Hirschowitz EA, Ohwada A, Pascal WR, Russi TJ, Crystal RG: In vivo adenovirus-mediated gene transfer of the Escherichia coli cytosine deaminase gene to human colon carcinoma-derived tumors induces chemosensitivity to 5-fluorocytosine. Hum Gene Therapy 6: 1055-1063, 1995
11. Kreuser ED, Wadler S, Thiel E: Biochemical modulation of cytotoxic drugs by cytokines: molecular mechanisms in experimental oncology. Recent Results in Cancer Research 139: 371-382, 1995
12. Mullen CA, Coale MM, Lowe R, Blaese RM: Tumors expressing the cytosine deaminase suicide gene can be eliminated in vivo with 5-fluorocytosine and induce protective immunity to wild type tumor. Cancer Res 54: 1503-1506, 1994
13. Pazdur R, Bready B, Moore DF Jr :Clinical trials of fluorouracil with α-interferon in advanced colorectal carcinomas. Seminars in Oncology 18: 67-70, 1991
14. Kirkwood JM: Studies of interferons in the therapy of melanoma. Seminars in Oncology 18: 83-90, 1991
15. Meadows LM, Walther P, Ozer H: α-Interferon and 5-fluorouracil: possible mechanisms of antitumor action. Seminars in Oncology 18: 71-76, 1991
16. Hoff DDV: In vitro data supporting Interferon plus cytotoxic agent combinations. Seminars in Oncology 18: 58-61, 1991
17. Neefe JR, John W: Mechanisms of interaction of interferon and 5-fluorouracil in solid tumors. Seminars in Oncology 18: 77-82, 1991
18. Grem JL, van Groeningen CJ, Ismail AA, Johnston PG, Alexander HR, Allegra CJ: The role of interferon-α as a modulator of fluorouracil and leucovorin. Eur J Cancer 31: 1316-1320, 1995
19. 2-induced DNA damage in bovine lens epithelial cell cultures. Exp Eye Res 49: 685-698, 1989
20. Houghton JA, Morton CL, Adkins DA, Rahman A: Locus of the interaction among 5-fluorouracil, leucovorin, and interferon-α2a in colon carcinoma cells. Cancer Res 53: 4243-4250, 1993
21. Maniatis T, Fritsch EF, Sambrook J: Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y. 2nd ed., 1989
22. Cornetta K, Anderson WF: Protamine sulfate as an effective alternative to polybrene in retroviral-mediated gene-transfer: implications for human gene therapy. J Virol Methods 23: 187-194, 1989
23. Karp JE, Broder S: New directions in molecular medicine. Cancer Res 54: 653-665, 1994
24. Lowe WL Jr, Meyer T, Karpen CW, Lorentzen LR: Regulation of insulin-like growth factor I production in rat C6 glioma cells: possible role as an autocrine/paracrine growth factor. Endocrinology 130: 2683-2691, 1992
25. Yalowich JC, Kalman TI: Rapid determination of thymidylate synthase activity and its inhibition in intact L1210 leukemia cells in vitro. Biochem Pharmacol 34: 2319-2324, 1985
26. Vile R, Russell SJ: Gene transfer technologies for the gene therapy of cancer. Gene Therapy 1: 88-98, 1994
27. Colombo BM, Benedetti S, Ottolenghi S, Mora M, Pollo B, Poli G, Finocchiaro G:The 'bystander effect': association of U-87 cell death with ganciclovir-mediated apoptosis of nearby cells and lack of effect in athymic mice. Hum Gene Therapy 6: 763-772, 1995
28. Yin MB, Rustum YM: Comparative DNA strand breakage induced by FUra and FdUrd in human ileocecal adenocarcinoma (HCT-8) cells: relevance to cell growth inhibition. Cancer Commun 3: 45-51, 1991